Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.43 |
| ▸ | POU2F2 | P09086 | 4/20 | 0.43 |
| ▸ | SLC22A2 | O15244 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4167533 | 0.76 | POU2F2 (0.44) | LIPGPOU2F2SLC22A2CYP3A4TMEM97 | |
| SCHEMBL2186003 | 0.74 | POU2F2 (0.45) | POU2F2SLC22A2CYP3A4TMEM97ABCG2 | |
| SCHEMBL4154425 | 0.74 | POU2F2 (0.47) | LIPGPOU2F2 | |
| SCHEMBL3528387 | 0.73 | POU2F2 (0.47) | LIPGPOU2F2 | |
| SCHEMBL17005272 | 0.73 | POU2F2 (0.45) | POU2F2SLC22A2 | |
| SCHEMBL81275 | 0.73 | POU2F2 (0.50) | POU2F2SLC22A2CYP3A4 | |
| SCHEMBL2187039 | 0.73 | POU2F2 (0.44) | POU2F2SLC22A2 | |
| SCHEMBL82602 | 0.73 | POU2F2 (0.51) | POU2F2SLC22A2CYP3A4TMEM97ABCG2 | |
| SCHEMBL3522619 | 0.72 | POU2F2 (0.48) | LIPGPOU2F2 | |
| SCHEMBL4176600 | 0.72 | POU2F2 (0.43) | LIPGPOU2F2SLC22A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858788-B2 | Bicyclic carbamoylpyridone derivative having HIV integrase inhibitory activity | SHIONOGI & CO., LTD. (JP) | 2010-12-28 | — | — | US | disclosed |